Prediction of therapeutic potency of tacrine derivatives as BuChE inhibitors from quantitative structure-activity relationship modelling.
Numerous studies show that tacrine derivatives exhibit increased inhibitory activity against butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE). However, the screening assays for currently available BuChE inhibitors are expensive, time consuming and dependent on the inhibitory compound. It is therefore desirable to develop alternative methods to facilitate the screening of these derivatives in the early phase of drug discovery. In order to develop robust predictive models, three regression methods were chosen in this study: multiple linear regression (MLR), support vector regression (SVR) and multilayer perceptron network (MLP). Eight relevant descriptors were selected on a dataset of 151 molecules using a method based on genetic algorithms. Internal and external validation strategies play an important role. Also, to check the robustness of the selected models, all available validation strategies were used, and all criteria used to validate these models revealed the superiority of the SVR model. The statistical parameters obtained with the SVR model were RMSE = 0.197, r2 = 0.969 and Q2 = 0.964 for the training set, and r2 = 0.906 and Q2 = 0.891 for the test set. Therefore, the model developed in this study provides an excellent prediction of the inhibitory concentration of tacrine derivatives.